Solstein Capital LLC Purchases New Stake in Elanco Animal Health (ELAN)

Solstein Capital LLC purchased a new stake in Elanco Animal Health (NASDAQ:ELAN) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 4,650 shares of the company’s stock, valued at approximately $149,000.

Other large investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. acquired a new stake in shares of Elanco Animal Health in the third quarter worth $38,358,000. Legal & General Group Plc acquired a new stake in shares of Elanco Animal Health in the third quarter worth $839,000. Morgan Stanley acquired a new stake in shares of Elanco Animal Health in the third quarter worth $314,448,000. Vanguard Group Inc. acquired a new stake in shares of Elanco Animal Health in the third quarter worth $176,182,000. Finally, State of Alaska Department of Revenue acquired a new stake in shares of Elanco Animal Health in the fourth quarter worth $261,000.

In other news, Director John P. Bilbrey bought 7,750 shares of Elanco Animal Health stock in a transaction dated Monday, May 13th. The shares were bought at an average price of $32.39 per share, for a total transaction of $251,022.50. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director R David Hoover bought 20,000 shares of Elanco Animal Health stock in a transaction dated Wednesday, March 13th. The stock was purchased at an average price of $31.43 per share, for a total transaction of $628,600.00. The disclosure for this purchase can be found here.

Shares of NASDAQ:ELAN traded down $0.17 on Monday, hitting $32.87. The stock had a trading volume of 8,024 shares, compared to its average volume of 7,695,552. Elanco Animal Health has a twelve month low of $28.00 and a twelve month high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last issued its earnings results on Thursday, May 9th. The company reported $0.25 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.03. The firm had revenue of $731.10 million during the quarter, compared to analyst estimates of $743.40 million. During the same quarter in the prior year, the firm posted $0.33 EPS. The firm’s revenue for the quarter was down .7% on a year-over-year basis.

ELAN has been the topic of several research analyst reports. UBS Group initiated coverage on shares of Elanco Animal Health in a research note on Wednesday, January 23rd. They issued a “sell” rating and a $29.00 price objective on the stock. William Blair initiated coverage on shares of Elanco Animal Health in a research note on Monday, February 11th. They set a “market perform” rating and a $29.71 price target on the stock. Zacks Investment Research downgraded shares of Elanco Animal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, March 5th. Morgan Stanley initiated coverage on shares of Elanco Animal Health in a research note on Wednesday, March 13th. They set an “equal weight” rating and a $34.00 price target on the stock. Finally, Bank of America upgraded shares of Elanco Animal Health from a “neutral” rating to a “buy” rating and set a $30.95 price target on the stock in a research note on Monday, March 18th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and seven have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $33.47.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://www.baseballdailydigest.com/news/2019/05/20/solstein-capital-llc-purchases-new-stake-in-elanco-animal-health-elan.html.

Elanco Animal Health Profile

There is no company description available for Elanco Animal Health Inc

Featured Article: Calculate Your Return on Investment (ROI)

Want to see what other hedge funds are holding ELAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elanco Animal Health (NASDAQ:ELAN).

Institutional Ownership by Quarter for Elanco Animal Health (NASDAQ:ELAN)

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.